MTNB Annual CFF
-$7000.00
-$86.00 K-108.86%
31 December 2023
Summary:
As of January 23, 2025, MTNB annual cash flow from financing activities is -$7000.00, with the most recent change of -$86.00 thousand (-108.86%) on December 31, 2023. During the last 3 years, it has fallen by -$48.05 million (-100.01%). MTNB annual CFF is now -100.01% below its all-time high of $48.05 million, reached on December 31, 2020.MTNB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTNB Quarterly CFF
-$67.00 K
-$9.26 M-100.73%
30 September 2024
Summary:
As of January 23, 2025, MTNB quarterly cash flow from financing activities is -$67.00 thousand, with the most recent change of -$9.26 million (-100.73%) on September 30, 2024. Over the past year, it has dropped by -$66.00 thousand (-6600.00%). MTNB quarterly CFF is now -100.14% below its all-time high of $47.44 million, reached on March 31, 2020.MTNB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTNB TTM CFF
$9.17 M
-$66.00 K-0.71%
30 September 2024
Summary:
As of January 23, 2025, MTNB TTM cash flow from financing activities is $9.17 million, with the most recent change of -$66.00 thousand (-0.71%) on September 30, 2024. Over the past year, it has increased by +$9.19 million (+83500.00%). MTNB TTM CFF is now -80.91% below its all-time high of $48.05 million, reached on December 31, 2020.MTNB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTNB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -108.9% | -6600.0% | +10000.0% |
| 3 y3 years | -100.0% | -6600.0% | +10000.0% |
| 5 y5 years | -100.0% | -6600.0% | +10000.0% |
MTNB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.1% | at low | -100.7% | at low | -0.7% | >+9999.0% |
| 5 y | 5-year | -100.0% | at low | -100.1% | at low | -80.9% | >+9999.0% |
| alltime | all time | -100.0% | at low | -100.1% | +59.9% | -80.9% | >+9999.0% |
Matinas BioPharma Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$67.00 K(-100.7%) | $9.17 M(-0.7%) |
| June 2024 | - | $9.19 M(>+9900.0%) | $9.24 M(>+9900.0%) |
| Mar 2024 | - | $53.00 K(-5400.0%) | $50.00 K(-814.3%) |
| Dec 2023 | -$7000.00(-108.9%) | -$1000.00(0.0%) | -$7000.00(-36.4%) |
| Sept 2023 | - | -$1000.00(0.0%) | -$11.00 K(-15.4%) |
| June 2023 | - | -$1000.00(-75.0%) | -$13.00 K(-27.8%) |
| Mar 2023 | - | -$4000.00(-20.0%) | -$18.00 K(-122.8%) |
| Dec 2022 | $79.00 K(-98.9%) | -$5000.00(+66.7%) | $79.00 K(-14.4%) |
| Sept 2022 | - | -$3000.00(-50.0%) | $92.30 K(+6.1%) |
| June 2022 | - | -$6000.00(-106.5%) | $87.00 K(-68.2%) |
| Mar 2022 | - | $93.00 K(+1020.5%) | $273.50 K(-96.1%) |
| Dec 2021 | $6.96 M(-85.5%) | $8300.00(-200.0%) | $6.96 M(-7.2%) |
| Sept 2021 | - | -$8300.00(-104.6%) | $7.51 M(-0.8%) |
| June 2021 | - | $180.50 K(-97.3%) | $7.57 M(+2.4%) |
| Mar 2021 | - | $6.78 M(+1134.4%) | $7.39 M(-84.6%) |
| Dec 2020 | $48.05 M(+61.0%) | $549.60 K(+914.0%) | $48.05 M(+1.1%) |
| Sept 2020 | - | $54.20 K(+1364.9%) | $47.51 M(+0.2%) |
| June 2020 | - | $3700.00(-100.0%) | $47.43 M(+0.4%) |
| Mar 2020 | - | $47.44 M(>+9900.0%) | $47.26 M(+58.3%) |
| Dec 2019 | $29.85 M(+88.1%) | $10.30 K(-152.8%) | $29.85 M(-21.9%) |
| Sept 2019 | - | -$19.50 K(-88.3%) | $38.20 M(-1.7%) |
| June 2019 | - | -$167.00 K(-100.6%) | $38.86 M(-15.6%) |
| Mar 2019 | - | $30.03 M(+259.2%) | $46.03 M(+190.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $15.87 M(+1.7%) | $8.36 M(+1200.9%) | $15.87 M(+102.2%) |
| Sept 2018 | - | $642.50 K(-90.8%) | $7.85 M(+1.2%) |
| June 2018 | - | $7.00 M(-5259.7%) | $7.76 M(+999.1%) |
| Mar 2018 | - | -$135.70 K(-140.0%) | $705.90 K(-95.5%) |
| Dec 2017 | $15.60 M(+123.0%) | $339.40 K(-38.6%) | $15.60 M(+2.2%) |
| Sept 2017 | - | $553.20 K(-1184.7%) | $15.27 M(-29.7%) |
| June 2017 | - | -$51.00 K(-100.3%) | $21.72 M(-0.2%) |
| Mar 2017 | - | $14.76 M(>+9900.0%) | $21.77 M(+211.1%) |
| Dec 2016 | $7.00 M(-17.3%) | $1800.00(-100.0%) | $7.00 M(-0.0%) |
| Sept 2016 | - | $7.01 M(<-9900.0%) | $7.00 M(-9050.3%) |
| June 2016 | - | -$800.00(-92.9%) | -$78.20 K(-101.9%) |
| Mar 2016 | - | -$11.30 K(-397.4%) | $4.16 M(-50.8%) |
| Dec 2015 | $8.46 M(>+9900.0%) | $3800.00(-105.4%) | $8.46 M(+0.0%) |
| Sept 2015 | - | -$69.90 K(-101.6%) | $8.45 M(-0.8%) |
| June 2015 | - | $4.24 M(-1.0%) | $8.52 M(+99.0%) |
| Mar 2015 | - | $4.28 M(>+9900.0%) | $4.28 M(>+9900.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2014 | - | $0.00(0.0%) | $13.03 M(-0.7%) |
| Mar 2014 | - | $0.00(0.0%) | $13.11 M(-2.9%) |
| Dec 2013 | $13.50 M | $0.00(-100.0%) | $13.50 M(0.0%) |
| Sept 2013 | - | $13.03 M(>+9900.0%) | $13.50 M(+2761.6%) |
| June 2013 | - | $86.30 K(-77.6%) | $471.70 K(+22.4%) |
| Mar 2013 | - | $385.40 K | $385.40 K |
FAQ
- What is Matinas BioPharma Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual CFF year-on-year change?
- What is Matinas BioPharma Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly CFF year-on-year change?
- What is Matinas BioPharma Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM CFF year-on-year change?
What is Matinas BioPharma Holdings annual cash flow from financing activities?
The current annual CFF of MTNB is -$7000.00
What is the all time high annual CFF for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual cash flow from financing activities is $48.05 M
What is Matinas BioPharma Holdings annual CFF year-on-year change?
Over the past year, MTNB annual cash flow from financing activities has changed by -$86.00 K (-108.86%)
What is Matinas BioPharma Holdings quarterly cash flow from financing activities?
The current quarterly CFF of MTNB is -$67.00 K
What is the all time high quarterly CFF for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly cash flow from financing activities is $47.44 M
What is Matinas BioPharma Holdings quarterly CFF year-on-year change?
Over the past year, MTNB quarterly cash flow from financing activities has changed by -$66.00 K (-6600.00%)
What is Matinas BioPharma Holdings TTM cash flow from financing activities?
The current TTM CFF of MTNB is $9.17 M
What is the all time high TTM CFF for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM cash flow from financing activities is $48.05 M
What is Matinas BioPharma Holdings TTM CFF year-on-year change?
Over the past year, MTNB TTM cash flow from financing activities has changed by +$9.19 M (+83500.00%)